Can Weight Loss Drugs Cause Nutrition Deficiencies?
Weight loss no longer has to be an exhausting uphill battle. Glucagon-like peptide-1 (GLP-1) drugs – sold under brand names such as Ozempic, Wegovy and Mounjaro – have revolutionised how we tackle obesity, delivering dramatic results through a simple injection.
Adults on the highest doses have been shown to lose more than a fifth of their body weight in 16 months, while gaining benefits for their liver, heart and even brain.
Little wonder these treatments are ferociously popular. In the US, approximately 12 per cent of adults say they’ve tried GLP-1s – that’s 41 million people. Across the Atlantic, an estimated 1.6 million adults in the UK took a weight-loss drug in the last year.
Excerpted from BBC Science Focus
